Detailed Information on Publication Record
2019
Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer
ABAD, Etna, Yoelsis GARCIA-MAYEA, Cristina MIR, David SEBASTIAN, Antonio ZORZANO et. al.Basic information
Original name
Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer
Authors
ABAD, Etna (724 Spain), Yoelsis GARCIA-MAYEA (724 Spain), Cristina MIR (724 Spain), David SEBASTIAN (724 Spain), Antonio ZORZANO (724 Spain), David POTĚŠIL (203 Czech Republic, belonging to the institution), Zbyněk ZDRÁHAL (203 Czech Republic, guarantor, belonging to the institution), Alex LYAKHOVICH (724 Spain) and Matilde LLEONART (724 Spain)
Edition
Molecular and Cellurar Proteomic, American Society for Biochemistry and Molecular Biology, 2019, 1535-9476
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.870
RIV identification code
RIV/00216224:14740/19:00107512
Organization unit
Central European Institute of Technology
UT WoS
000457454000005
Keywords in English
STEM-CELLS; DYSFUNCTION; AUTOPHAGY; HYDROXYCHLOROQUINE; TOXICITY; TARGET; GROWTH; ACID
Tags
International impact, Reviewed
Změněno: 2/11/2024 20:19, Ing. Martina Blahová
Abstract
V originále
Cancer cells are known to reprogram their metabolism to adapt to adverse conditions dictated by tumor growth and microenvironment. A subtype of cancer cells with stem-like properties, known as cancer stem cells (CSC), is thought to be responsible for tumor recurrence. In this study, we demonstrated that CSC and chemoresistant cells derived from triple negative breast cancer cells display an enrichment of up-and downregulated proteins from metabolic pathways that suggests their dependence on mitochondria for survival. Here, we selected antibiotics, in particular - linezolid, inhibiting translation of mitoribosomes and inducing mitochondrial dysfunction. We provided the first in vivo evidence demonstrating that linezolid suppressed tumor growth rate, accompanied by increased autophagy. In addition, our results revealed that bactericidal antibiotics used in combination with autophagy blocker decrease tumor growth. This study puts mitochondria in a spotlight for cancer therapy and places antibiotics as effective agents for eliminating CSC and resistant cells.
Links
GBP206/12/G151, research and development project |
| ||
LQ1601, research and development project |
| ||
90043, large research infrastructures |
|